- Examining selection and justification of starting materials for drug substances
- Discussing the latest developments from the FDA, EMA, and ICH and the impact on pharma customer-supplier requirements
- Defining project scope and cost in external development and manufacturing
- Case study: Commercializing a recently approved antibiotic